Invention Grant
- Patent Title: Treatment of alphavirus-induced inflammation
-
Application No.: US16884628Application Date: 2020-05-27
-
Publication No.: US11638718B2Publication Date: 2023-05-02
- Inventor: Surendran Mahalingam , Lara Josefina Herrero
- Applicant: GRIFFITH UNIVERSITY
- Applicant Address: AU Nathan
- Assignee: GRIFFITH UNIVERSITY
- Current Assignee: GRIFFITH UNIVERSITY
- Current Assignee Address: AU Nathan
- Agency: Thorpe North & Western, LLP
- Main IPC: A61K31/737
- IPC: A61K31/737 ; A61P19/02 ; A61P31/14 ; A61P29/00 ; A61K9/00

Abstract:
Disclose is a method of treating alphavirus infections, particularly in humans, in which pentosan polysulfate is administered to an infected subject. Whilst not effecting the viral load in a subject, the pentosan polysulfate acts to reduce inflammation in tissues, such as the muscles, and in the joints of a subject. In addition, cartilage damage in the joints may be reduced. The reduction in inflammation and/or cartilage damage acts to reduce the severe pain experienced by subjects suffering from alphavirus infections, such as Ross River virus, chikungunya virus and Barmah Forest virus.
Public/Granted literature
- US20210023124A1 TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION Public/Granted day:2021-01-28
Information query
IPC分类: